Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Pulmonescence Diagnostics, Inc.
Street 1: 328 S Hertzler Rd
Street 2:
City: Elizabethtown
Province: PA
Post Code: 17022
Country: United States of America
Phone: 9792242698
Organization Email:
Web Site: http:// in progress
Other Online Presence:

Focal Point Contact Information

Salutation: Dr.
First Name: Joe
Last Name: JILKA
Title: CEO
Phone: 9792242698

Alternate Focal Point Contact Information

Salutation: Dr.
First Name: Saurabh
Last Name: Biswas
Title: President

General Information

Board Constituency: None
Is your organization legally registered in your country: Yes
If yes, please enter your registration number: Delaware SR 20185845784
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Organization Description:
Pulmonescence Diagnostics is developing a simple, low-cost, revolutionary TB diagnostic that not only tracks, detects and diagnoses tuberculosis with a sensitivity beyond existing technologies but also incorporates a drug sensitivity test in the same test.
Do you know about the UNHLM declaration: Yes

Specializations / Areas of Work

Research and Development

Other Organization Information

Total number of staff in your organization: 1 - 5
Number of full-time staff who are directly involved with TB: 1 - 5
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
How did you hear about the Stop TB Partnership: Internet search
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Network with other partners
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
Pulmonescence Diagnostics is working to advance a low-cost point-of- care diagnostic system, designated reporter enzyme fluorescence for TB (REFtb), a rapid POC diagnostic system for tuberculosis that can also identify drug resistant strains in limited-resource settings with minimal specialized training or limited logistic assistance.

Geographical Reach

Which country is your headquarters located in: United States of America
Which countries do you do operate in:
(This includes countries you are conducting activities in)


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

New Diagnostics:
Development of a novel rapid and accurate detection of all forms of TB cases for
appropriate treatment.


Declaration of interests:
No conflicts of interest were delacred.

Application date: November 27, 2018
Last updated: November 27, 2018